174 related articles for article (PubMed ID: 21071502)
1. Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study.
Even C; Bastuji-Garin S; Hicheri Y; Pautas C; Botterel F; Maury S; Cabanne L; Bretagne S; Cordonnier C
Haematologica; 2011 Feb; 96(2):337-41. PubMed ID: 21071502
[TBL] [Abstract][Full Text] [Related]
2. Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with leukemia.
Pokala HR; Leonard D; Cox J; Metcalf P; McClay J; Siegel J; Winick N
Pediatr Blood Cancer; 2014 Feb; 61(2):276-80. PubMed ID: 23970381
[TBL] [Abstract][Full Text] [Related]
3. Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy.
Park H; Youk J; Shin DY; Hong J; Kim I; Kim NJ; Lee JO; Bang SM; Yoon SS; Park WB; Koh Y
BMC Cancer; 2019 Apr; 19(1):358. PubMed ID: 30991992
[TBL] [Abstract][Full Text] [Related]
4. Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience.
Girmenia C; Frustaci AM; Gentile G; Minotti C; Cartoni C; Capria S; Trisolini SM; Matturro A; Loglisci G; Latagliata R; Breccia M; Meloni G; Alimena G; Foà R; Micozzi A
Haematologica; 2012 Apr; 97(4):560-7. PubMed ID: 22102706
[TBL] [Abstract][Full Text] [Related]
5. Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).
Caira M; Candoni A; Verga L; Busca A; Delia M; Nosari A; Caramatti C; Castagnola C; Cattaneo C; Fanci R; Chierichini A; Melillo L; Mitra ME; Picardi M; Potenza L; Salutari P; Vianelli N; Facchini L; Cesarini M; De Paolis MR; Di Blasi R; Farina F; Venditti A; Ferrari A; Garzia M; Gasbarrino C; Invernizzi R; Lessi F; Manna A; Martino B; Nadali G; Offidani M; Paris L; Pavone V; Rossi G; Spadea A; Specchia G; Trecarichi EM; Vacca A; Cesaro S; Perriello V; Aversa F; Tumbarello M; Pagano L;
Haematologica; 2015 Feb; 100(2):284-92. PubMed ID: 25638805
[TBL] [Abstract][Full Text] [Related]
6. Management of Invasive Fungal Infections in Pediatric Acute Leukemia and the Appropriate Time for Restarting Chemotherapy.
Tüfekçi Ö; Yılmaz Bengoa Ş; Demir Yenigürbüz F; Şimşek E; Karapınar TH; İrken G; Ören H
Turk J Haematol; 2015 Dec; 32(4):329-37. PubMed ID: 25913290
[TBL] [Abstract][Full Text] [Related]
7. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.
Wiley JM; Smith N; Leventhal BG; Graham ML; Strauss LC; Hurwitz CA; Modlin J; Mellits D; Baumgardner R; Corden BJ
J Clin Oncol; 1990 Feb; 8(2):280-6. PubMed ID: 2299371
[TBL] [Abstract][Full Text] [Related]
8. Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
Dahlén T; Kalin M; Cederlund K; Nordlander A; Björkholm M; Ljungman P; Blennow O
Eur J Haematol; 2016 Feb; 96(2):175-80. PubMed ID: 25880378
[TBL] [Abstract][Full Text] [Related]
9. Incidence and management of proven and probable fungal infections in patients with acute leukemia: a single center experience.
Fanci R; Casini C; Leoni F; Ciolli S; Bosi A
J Chemother; 2004 Dec; 16(6):557-60. PubMed ID: 15700847
[TBL] [Abstract][Full Text] [Related]
10. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D
N Engl J Med; 2007 Jan; 356(4):348-59. PubMed ID: 17251531
[TBL] [Abstract][Full Text] [Related]
11. Incidence and outcomes of invasive fungal disease in adult patients with acute lymphoblastic leukemia treated with hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone: implications for prophylaxis.
Henden A; Morris K; Truloff N; Nakagaki M; Kennedy GA
Leuk Lymphoma; 2013 Jun; 54(6):1329-31. PubMed ID: 23072370
[No Abstract] [Full Text] [Related]
12. Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy.
Gözdaşoĝlu S; Ertem M; Büyükkeçeci Z; Yavuzdemir S; Bengisun S; Ozenci H; Taçyildiz N; Unal E; Yavuz G; Deda G; Aysev D
Med Pediatr Oncol; 1999 May; 32(5):344-8. PubMed ID: 10219335
[TBL] [Abstract][Full Text] [Related]
13. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
[TBL] [Abstract][Full Text] [Related]
14. Voriconazole prophylaxis in leukemic patients: A retrospective single-center study.
Bui V; Walker SA; Elligsen M; Vyas A; Kiss A; Palmay L
J Oncol Pharm Pract; 2020 Jun; 26(4):873-881. PubMed ID: 31566111
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal infections in patients with acute leukemia.
Hsiao HH; Tsai HJ; Liu YC; Tseng YT; Lu PL; Yang WC; Liu TC; Lin SF
Kaohsiung J Med Sci; 2006 May; 22(5):217-22. PubMed ID: 16793556
[TBL] [Abstract][Full Text] [Related]
16. [Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia].
Andrade M A; Puga L B; Guerra C C; Molina E J; Capurro C M
Rev Med Chil; 2011 Sep; 139(9):1128-34. PubMed ID: 22215390
[TBL] [Abstract][Full Text] [Related]
17. SEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapy.
Busca A; Lessi F; Verga L; Candoni A; Cattaneo C; Cesaro S; Dragonetti G; Delia M; De Luca A; Guglielmi G; Tumbarello M; Martino G; Nadali G; Fanci R; Picardi M; Potenza L; Nosari A; Aversa F; Pagano L;
Leuk Lymphoma; 2017 Dec; 58(12):2859-2864. PubMed ID: 28508692
[TBL] [Abstract][Full Text] [Related]
18. Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome.
Cattaneo C; Gramegna D; Malagola M; Pagani C; Borlenghi E; Cerqui E; Passi A; Sciumé M; Bernardi S; Crippa C; Dalceggio D; Carbone C; Pelizzari AM; Re A; Russo D; Rossi G
Leuk Lymphoma; 2019 Dec; 60(12):3044-3050. PubMed ID: 31120311
[TBL] [Abstract][Full Text] [Related]
19. High Infection-Related Mortality in Pediatric Acute Myeloid Leukemia without Preventive Antibiotics and Antifungals: Retrospective Cohort Study of a Single Center from a Middle-Income Country.
Zengin E; Sarper N; Aylan Gelen S; Demirsoy U; Karadoğan M; Çakı Kılıç S; Öncel S; Arısoy ES; Dündar D
Turk J Haematol; 2017 Dec; 34(4):340-344. PubMed ID: 28351828
[TBL] [Abstract][Full Text] [Related]
20. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
